newsfilter
← Latest News
ACCESS Newswire·

Halberd Receives Patent for Treatment of Cockayne Syndrome - May Provide Pathway to Slow Aging

JACKSON CENTER, PA / ACCESSWIRE / August 25, 2021 / Halberd Corporation (OTC:HALB) received notification from the Ference Law Firm in Pittsburgh of a Notice of Allowance, by the US Patent Office, for the treatment of Cockayne Syndrome. Cockayne Syndrome